What is Fennec Pharmaceuticals Inc (FENC) stock price today?

Fennec Pharmaceuticals Inc (FENC) currently trades at $6.26 per share. The stock has a market capitalization of $235.81M and a P/E ratio of —x.

Is FENC stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Fennec Pharmaceuticals Inc has a Smart Value Score of 36/100 (Grade D), resulting in a "Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Fennec Pharmaceuticals Inc's revenue and earnings?

Fennec Pharmaceuticals Inc has trailing twelve-month (TTM) revenue of $44.64M with profit margins of -21.80%. Earnings per share (EPS) is $-0.34.

FENC

Fennec Pharmaceuticals Inc

NASDAQ: FENC · HEALTHCARE · BIOTECHNOLOGY

$6.26

-6.57% today

Updated 2026-04-29

Market cap

$235.81M

P/E ratio

—

P/S ratio

5.28x

EPS (TTM)

$-0.34

Dividend yield

—

52W range

$6 – $10

Volume

0.2M

Market cap

$235.81M

P/E ratio

—

P/S ratio

5.28x

EPS (TTM)

$-0.34

Dividend yield

—

52W range

$6 – $10

Volume

0.2M

WallStSmart proprietary scores

out of 100

Grade: D

Sell

Investment rating

8.0

Growth

5.0

Quality

C+

2.0

Profitability

5.3

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$15.17

+142.33%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy5 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 73.80% QoQ

Risks

- Thin margins at -21.80%

- Negative free cash flow $-5.96M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$1.47M	$21.25M	$47.54M	$45.42M	$44.64M
Net income	$-22.77M	$-16.05M	$-436000.00	$-10.27M	$-5.22M
EPS	—	—	—	—	$-0.34
Free cash flow	$-18.06M	$-17.14M	$26.98M	$-12.47M	$-5.96M
Profit margin	-1,544.89%	-75.50%	-0.92%	-22.62%	-21.80%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
FENC	$235.81M	36	8.0	2.0	5.3	5.0	—	Hold
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Fennec Pharmaceuticals Inc trades at $6.26. Our Smart Value Score of 36/100 indicates the stock is weak. TTM revenue stands at $44.64M. with profit margins at -21.80%.

Frequently asked questions

What is Fennec Pharmaceuticals Inc's stock price?

Fennec Pharmaceuticals Inc (FENC) trades at $6.26.

Is Fennec Pharmaceuticals Inc overvalued?

Smart Value Score 36/100 (Grade D, Sell).

What is the price target of Fennec Pharmaceuticals Inc (FENC)?

The analyst target price is $15.17, representing +142.3% upside from the current price of $6.26.

What is Fennec Pharmaceuticals Inc's revenue?

TTM revenue is $44.64M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio5.28x

ROE-65.80%

Beta0.93

50D MA$7.32

200D MA$8.04

Shares out0.03B

Float0.02B

Short ratio—

Avg volume0.2M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

FENC vs LLY →FENC vs JNJ →FENC vs ABBV →Stock screener →